Biotech events - Theoria Creative

ASGCT 27th Annual Meeting
2024-05-07 - 2024-05-11
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. ASGCT’s annual meeting brings together more than 3,400 professionals including scientists, physicians, and patient advocates.

2024 AAPS National Biotechnology Conference
2024-05-13 - 2024-05-16
Track 1: Advances in Discovery, Formulation, and Delivery of New Modalities
A tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and new modalities. Submissions are invited on topics related to multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, cells, and allogenic and synthetic cells. Discussions are encouraged on diverse strategies for the discovery, formulation, and delivery of these modalities to address unmet medical needs.
Track 2: Novel Strategies to Advance Biotherapeutic Development
Advances in therapeutic development for targeted delivery, platform technology, high-content bioanalysis, and data science.

Annual Meeting of the International Society for Cell & Gene Therapy (ISCT)
2024-05-29 - 2024-06-01
CUTTING EDGE TRANSLATIONAL CONTENT
Connect with global experts from across academic, regulatory, and industry. Participate in robust debates, collaborate on developing solutions to sector challenges, and secure a front-row seat to presentations and conversations advancing the field of cell and gene therapy.
50+ Roundtable Sessions: Developed by harnessing the expertise of key opinion leaders from ISCT expert committees, ISCT 2024 roundtable sessions provide an interactive platform for in-depth discussions and debates on pivotal subjects including iPSCs, exosomes, CAR-Ts, artificial intelligence, bio-manufacturing and regulatory harmonization.
Join our roundtable sessions to remain well-informed on solutions to the sector’s most pressing challenges, engage in conversations propelling the industry forward, and forge connections with potential future collaborators.
Translational Pathway Program: Immerse yourself in the future of cell and gene therapy with thought-provoking talks and presentations from the most esteemed cell and gene therapy leaders from across the globe. Our Translational Pathway Program provides key education and data on the most novel research spanning the spectrum of translation including science and innovation, translation to the clinic, first in human to clinical acceleration, launch and patient access.
Attend our plenary and concurrent sessions to discover the latest breakthroughs in gene-edited EVs, autologous and allogeneic iPSC clinical trials, CAR-Ts, NK cells, Tregs, point-of-care manufacturing, clinical site qualification standardization, investment and partnering.
Global Showcases & Corporate Sessions: Hear directly from industry leaders representing prominent international organizations to discover the current status of commercialization efforts in the cell and gene sector. Gain firsthand knowledge and education about the revolutionary technologies on the horizon that are poised to define the future of cell and gene therapy.

Annual Oncology Innovation Summit: Insights for ASCO & EHA
2024-05-31 - 2024-06-04
Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.
The 2024 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme: The Art and Science of Cancer Care: From Comfort to Cure.

NNS 41st annual Neurotrauma Symposium
2024-06-09 - 2024-06-12
It is our distinct pleasure to invite you to attend the 41st annual National Neurotrauma Society Symposium, to be held in San Francisco, CA on June 9 – 12th, 2024, at the San Francisco Hilton Union Square. As in previous years, the NNS will co-host this meeting with the American Association of Neurological Surgeons/CNS Joint Section on Neurotrauma & Critical Care.
We look forward to seeing everyone in San Francisco!
Since its inception, the NNS symposia have brought together scientists, clinicians, and health-care providers who are dedicated to the study of neurotrauma and to translating knowledge generated by research into improved patient care.
Join your colleagues and initiate new collaborations at the premier forum for information related to traumatic brain injury and spinal cord injury.
The annual Neurotrauma Symposia are co-hosted by the National Neurotrauma Society and the American Association Neurological Surgeons and Joint Section on Neurotrauma and Critical Care (AANS/CNS). This combination of expertise allows for presentations that integrate state-of-the-art clinical, translational, and basic science data. Share with others what function means to you and hear about cutting edge approaches to assessing and improving function after neurotrauma.
The Scientific Program Committees are charged with putting together programs comprised of plenary and break-out sessions in which the leading experts will share their up-to-date research and findings in neurotrauma.
A central focus of the Symposium are the highly interactive poster sessions which stimulate scholarly discussions on the mechanisms, assessments and treatments for improving function after neurotrauma.

STING & TLR Targeted Therapies Summit
2024-06-19 - 2024-06-20
The STING & TLR Targeted Therapies Summit returns as the only industry-led event converging those with crucial insights to fuel the long-awaited success of innate immunity targeted therapies.
With the field venturing into new approaches to strike that balance between safety and efficacy, from immune agonist conjugates to combination approaches and novel dosing methods, stay ahead of this evolving field with the latest insights to steer you towards success in the clinic.
The therapeutic potential of harnessing the innate immune system has been waiting to be untapped for a while. Hear from the leading minds in immune-oncology and join the dedicated community to breakthrough barriers to success within your innate immunotherapy pipeline.

PHC's Health Equity Leadership Summit
2024-07-11 - 2024-07-12
This event provides an opportunity for physicians, executives, advocates, and allies to find community, engage in hands-on trainings and workshops, and hold in-depth conversations about how they are addressing the issue of health equity in California through their care of underserved communities throughout the state.
Attendees will leave feeling energized and inspired to continue their important work to improve the lives of all Californians.

16th Annual BioProcessing Summit
2024-08-19 - 2024-08-22
Welcome to the Bioprocessing Summit!
Join us as we bring together thought leaders and pioneers in bioprocess R&D, scale-up, quality, and analytics. Explore cutting-edge research, exchange insights with industry experts, and chart the course for advancements that will shape the future of bioprocessing.
The Summit features main conference sessions, in-depth training seminars, a 1-day investor conference for C-level executives, a workshop dedicated to talent recruitment, acquisition and retention strategies, an engaging exhibit hall and a plethora of networking opportunities. Elevate your knowledge, expand your network, and be at the forefront of bioprocess innovation.

Informa RNA Leaders USA Congress
2024-09-04 - 2024-09-05
RNA Leaders USA Congress helps you to discover, develop & get to market by assessing new data & case studies from global RNA experts across Oligo-Based Therapeutics, mRNA Vaccines & Therapeutics and Next Gen RNA & Delivery Tools.

Charles River Biotech Symposium
2024-09-08 - 2024-09-11
The Charles River Biotech Symposium unites drug development professionals in an interactive setting to discuss the nonclinical development of biotherapeutics, including regulatory issues and innovative approaches to problem solving. The collegial spirit of this meeting creates exceptional opportunities for information sharing and networking. Please join us in beautiful Southern California for another unique and exciting educational opportunity.

Fierce Digital Pharma East
2024-09-09 - 2024-09-12
Digital Pharma East is dedicated to advancing pharma marketing innovation beyond limits. Get ready for an immersive, informative, and thought-provoking event featuring top-tier keynote speakers, insightful case studies, engaging panel discussions, and much more.

ESMO Congress 2024
2024-09-13 - 2024-09-17
The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world.
The innovative, LIVE Plus Congress format will offer participants the option to attend in person, in Barcelona or online, through the Virtual Congress Platform, from 13-17 September 2024.
See you there!

149th Meeting of the ANA
2024-09-14 - 2024-09-17
Join us in-person for the 2024 American Neurological Association Annual Meeting (ANA2024) from September 14-17, 2024, at the Hilton Orlando in Orlando, FL.
The ANA’s 149th Annual Meeting will convene the nation’s top academic neurologists and neuroscientists. The Meeting will feature six main symposia, which highlight groundbreaking conceptual and therapeutic advances in a variety of neurologic disease states, as well as interactive lunch workshops, special interest group sessions, and the ANA’s celebrated poster sessions.
Other Meeting highlights include:
Presidential Symposium
Opening Symposium on Saturday evening (September 14)
Plenary Sessions on key scientific advances
Professional Development Courses for academic neurologists at every career level
Interactive Lunch Workshop sessions
Special Interest Group (SIG) Sessions
Women of the ANA luncheon
And much, much more!

Consequences of Aneuploidy
2024-09-15 - 2024-09-19
Having recently launched in 2022, this exciting new SRC will gather researchers involved in how aneuploidy affects physiology and how it contributes to diseases associated with its development (e.g., congenital disorders) or aging (e.g., cancer). The conference will also represent an opportunity for junior and early-career scientists and those from historically excluded groups to showcase their work, develop mentoring relationships, and network with colleagues in this exciting discipline.
This conference will address some of the pressing questions surrounding aneuploidy such as:
What are the fates of aneuploid cells during development, tumor progression, and aging?
What are the universal vs. chromosome- or tissue-specific consequences of aneuploidy?
What are the vulnerabilities of aneuploid cells?

Southern California BioLife Summit
2024-09-18
California Life Sciences is proud to co-host the Southern California BioLife Summit, an annual event that convenes industry leaders, researchers, and entrepreneurs to discuss advancements and opportunities in biotechnology and life sciences. One-on-one meetings, panel discussions and presentations will offer insights into the newest breakthroughs and trends in the field.

Informa Cell & Gene Therapy International
2024-09-23 - 2024-09-26
Informa Cell & Gene Therapy International assist in accelerating your journey from bench to bedside & bridges the gap to patient access. Learn how to mitigate risk with best practices and experiences for building end to end supply chains, and reliable distribution networks, for your Cell & Gene Therapy Products.

Fierce MASS West
2024-09-25 - 2024-09-26
The Fierce Medical Affairs Strategic Summit West provides a platform for medical affairs, field medical, and medical communications teams to share best practices and gain actionable insights from their peers including out of the box strategies for MSLs to engage with KOLs and HCPs post-pandemic, successful approaches to establishing medical communications plans ahead of a launch, and the role of medical affairs in delivering a truly omnichannel customer experience.

2024 CNS Annual Meeting
2024-09-28 - 2024-10-02
The CNS Mission:
Enhancing health and improving lives through the advancement of neurosurgical education and scientific exchange

Fierce Biotech Summit
2024-09-30 - 2024-10-01
Join us attendees at the Fierce Biotech Summit where leaders and seasoned executives will come together to discuss the future of the industry. Brought to you by the editors behind Fierce Biotech, this three-day event will cover the use of AI in drug development, unique dealmaking strategies, the latest innovations in oncology and much more.

Discovery on Target
2024-09-30 - 2024-10-03
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
We aim to meet your research needs. Visit numerous concurrent sessions all week for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses, training seminars, interactive breakout discussions, and networking options that help you engage with experts and solutions providers.
Our four-day event brings back popular topics like kinases, immunomodulation, and degraders, plus new coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models.

West Coast Summit: The Transformative Power of AI in Pharmaceutical R&D
2024-10-03
Johnson & Johnson and California Life Sciences have joined forces to produce our West Coast Summit: The Transformative Power of AI in Pharmaceutical R&D. Join us as we convene expert perspectives from the pharmaceutical industry, the startup world and the investor community – focused on how AI is driving the discovery, development and delivery of innovative medicines today, and what the future holds in this rapidly-evolving space.

Neuroscience 2024
2024-10-05 - 2024-10-09
Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall.
Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at an SfN annual meeting — the premier global neuroscience event.

Cell & Gene Meeting on the Mesa
2024-10-07 - 2024-10-09
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

7th Annual Scientific Session for The AASCP
2024-10-18 - 2024-10-20
The American Academy of Stem Cell Physicians is a leading organization dedicated to advancing the field of regenerative medicine and stem cell therapies.
Our upcoming seventh annual scientific session promises to be a gathering of some of the most prominent minds in the field, providing a platform for the exchange of cutting-edge research, clinical advancements, and best practices. With a focus on interdisciplinary collaboration and evidence-based approaches, the event is expected to delve into the latest breakthroughs and applications of stem cell therapies, offering valuable insights that will shape the future of regenerative medicine.

American Academy of Ophthalmology (AAO) Annual Meeting 2024
2024-10-18 - 2024-10-21
AAO 2024 is the American Academy of Ophthalmology’s annual event, taking place October 18-21, 2024, at McCormick Place in Chicago. The event includes educational sessions, an expo showcasing the latest ophthalmic innovations, and specialized programs like Subspecialty Day. Attendees can also join the Saturday Night Celebration on October 19.

ASN Kidney Week 2024
2024-10-23 - 2024-10-27
Join ASN and over 12,000 other kidney professionals from across the globe at Kidney Week 2024 in San Diego, CA. The world’s premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field.

39th SITC Annual Meeting & Pre-Conference Programs
2024-11-06 - 2024-11-10
SITC 2024 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. SITC 2024 also includes updates on major national and international initiatives from academia, government and industry, as well as important society projects.
The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®
2024-11-13 - 2024-11-15
Overview
Now in its 42nd year, the Chemotherapy Foundation Symposium (CFS®) brings together thousands of health care professionals for an exciting 3-day conference that promotes the delivery of evidence-based, state-of-the-art cancer care. Internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering a unique opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize clinical care for your patients with cancer.
Exciting new developments and rapid changes continue to occur in the management of solid and hematologic malignancies. In the past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to do so. Optimized testing and treatments for early and advanced disease, including chemotherapeutics, targeted therapies, immunotherapies—alone and in combination—and multimodal strategies continue to improve clinical outcomes. CFS® offers you the critical knowledge you need to safely and effectively integrate these strategies into your practice.

American Pharma Manufacturing & Outsourcing Summit
2024-11-18 - 2024-11-19
About the American Pharma Manufacturing & Outsourcing Summit

The Generis American Pharma Manufacturing & Outsourcing Summit sets the standard on how the industry should connect and exchange ideas.
Our pharma outsourcing and pharma manufacturing conference is designed to provide pharmaceutical executives with current trends, strategic insights, and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics.
This executive pharma event brings together manufacturing and supply chain-focused leaders involved in pharmaceutical manufacturing and outsourcing.
Network with over 150 of your fellow pharma leaders as we explore strategies to maximize efficiency while remaining compliant in this ever-evolving environment.

5th Genome Editing Therapeutics Summit
2024-12-03 08:00 - 2024-12-05 17:00 (America/Los_Angeles)
Leverage Cutting-Edge Genome Editing Technology to Accelerate Safe, Precise and Regulatory-Compliant Therapies into the Clinic

Welcome to the 5th Annual Genome Editing Therapeutics Summit

Only 11 years after Emmanuelle Charpentier and Jennifer Doudna’s seminal paper, Casgevy marks the remarkable first approval of a gene editing therapy, a landmark moment for a still-developing field. Following closely is a growing pipeline of precision genome editing techniques that are beginning to revolutionize the treatment of genetic diseases.
The 5th Genome Editing Therapeutics Summit (formerly CRISPR 2.0) is the industry’s foremost meeting for spearheading the development, application, and delivery of novel gene editing technologies in the therapeutic setting. Data-driven talks, expert panel discussions, and interactive group discussions will cover the therapeutic application and drug development challenges of both:

More established technologies, and their associated translational, nonclinical, clinical, and strategic challenges: including novel nucleases, base, prime, and multiplex editing techniques

Ground-breaking precision tools enabling small and large alterations to the genome, including epigenome editing, recombinase and transposon-based technologies, and novel delivery vehicles

Across three days, industry and academic leaders will share the latest data on the cutting-edge therapies they are progressing through development, tying in the strategies they are deploying to ensure their safety, precision, and regulatory compliance.
This is the industry’s only gene editing meeting that prioritizes drug development first, with a particular focus on robust safety packages, off-target detection, and nomination strategies; facilitating successful IND filings. Leverage actionable insights to improve the precision and safety of your technology, unlock the ability to perform small and large targeted edits, and outline a streamlined path to clinic for your lead program.
Join us to be a part of the gene editing revolution.
